Ikena Oncology, Inc. (IKNA)
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, an oral inhibitor of aryl hydrocarbon receptor; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.
$82.52M
Dr. Mark Manfredi Ph.D.
78.00
Boston, MA
Mar 26, 2021
-1.20
$-1.42
5.40
18.22
-3,617.57%
-1.21
0.00
0.56
43.70
18.22
-42.36%
-42.81%
Similar stocks (16)
Kymera Therapeutics, Inc.
KYMR
Edgewise Therapeutics, Inc.
EWTX
Nurix Therapeutics, Inc.
NRIX
Stoke Therapeutics, Inc.
STOK
Celcuity Inc.
CELC
Eliem Therapeutics, Inc.
ELYM
Foghorn Therapeutics Inc.
FHTX
Monte Rosa Therapeutics, Inc.
GLUE
Design Therapeutics, Inc.
DSGN
Rezolute, Inc.
RZLT
Shattuck Labs, Inc.
STTK
Werewolf Therapeutics, Inc.
HOWL
MediciNova, Inc.
MNOV
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
Xilio Therapeutics, Inc.
XLO
ETF Exposure (9)
iShares Micro-Cap ETF
IWC
0.01308%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (16)
Kymera Therapeutics, Inc.
KYMR
Edgewise Therapeutics, Inc.
EWTX
Nurix Therapeutics, Inc.
NRIX
Stoke Therapeutics, Inc.
STOK
Celcuity Inc.
CELC
Eliem Therapeutics, Inc.
ELYM
Foghorn Therapeutics Inc.
FHTX
Monte Rosa Therapeutics, Inc.
GLUE
Design Therapeutics, Inc.
DSGN
Rezolute, Inc.
RZLT
Shattuck Labs, Inc.
STTK
Werewolf Therapeutics, Inc.
HOWL
MediciNova, Inc.
MNOV
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
Xilio Therapeutics, Inc.
XLO
ETF Exposure (9)
iShares Micro-Cap ETF
IWC
0.01308%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%